ACROresident

⏳ The clock is ticking! ACRO’s spring scholarships are due April 17th. ⚛️ HIT Scholarship: acro.org/page/HITSchola… 🌍 GROW Scholarship: acro.org/page/GROWSchol… 📚 Luther Brady Grants: acro.org/page/LutherBra… 🌱 Seed Grants: acro.org/page/SeedGrants #ACRO

Theranostics with @jmmrad!

Polaroids + Positivity 📸 A few snaps from our #ACRO2026 Wellness Reception. Taking time to recharge and reconnect with our #radonc besties! 🌟

Our first full day of #ACRO2026 was one for the books, packed with insight, innovation, and connection.! 🌟 See more photos on our Instagram: instagram.com/p/DUa2C9gDddg/…

💥SBRT Beyond Tumor Control Dr. Michael Buckstein shares how we can improve patient QoL through celiac plexus tx in GI cancers & how we can convince our colleagues to help our patients Neurolysis of nerves—not tumor targeting—and it’s SAFE @ACRORadOnc @ACROresident #ACRO2026

Wonderful talks by Dr. Dominique Rash, Dr. Onyinye Balogun, and med student Danielle Jones on management of medically inoperable endometrial cancer, considerations for hybrid/interstitial brachy, & impact on OARs at #ACRO2026 👏

We are having a great time connecting at #ACRO2026! Share your photos with us to repost. :) @ACROresident @ACRORadOnc @kellyhomd

👏 Outstanding talk by @ldawsonmd, our HCC 👸🏻 Clear 💪 story of how EBRT meaningfully integrates into pt care for HCC across all BCLC stages, but esp. in tumors with MVI 🙏🏻 enroll in GI012 @NRGonc to help us answer the❓IO +/- SBRT in unresectable HCC @ACRORadOnc #ACRO2026

Dr. Choi is starting off our educational sessions strong with a fabulous presentation about breast cancer and locoregional recurrence #ACRO #ACROSummit2026

It's standing room only for our #ACRO2026 @ACROresident program! The enthusiasm and engagement from these radiation oncologists in-training speaks volumes about the future of our field. #RadiatingExcellence #radiationoncology #radonc

Good morning from #ACRO2026! ACRO President @blally_md officially opened the Summit with a warm welcome to kick off an exciting few days ahead.

Thank you so much @DigiaimoRon !!

More amazing talks from #ACRO2026 breast session! Big takeaways: - Ahead of NRG BR008, NCDB analysis suggests OS benefit to RT even in low risk Her2+ pts - Ongoing studies to delay SGY for DCIS patients, and prospective studies for omitting RT for low genomic risk DCIS

Amazing talk from our 🌟 PD @ChelseaPinnix on using ultra-low dose RT ☢️ for MALT & low-grade cutaneous B cell lymphomas 👏💪 We are 🙏🏻 to learn from her every day in @MDAndersonNews #radonc program, but it was still a treat🍭 to👂her speak at #ACRO2026 @ACRORadOnc @ACROresident

🔊 The wait is over! We’re ready to spend the next few days #RadiatingExcellence with the best in the field. See you tomorrow at #ACRO2026! 📣 @ACROresident @ACROSEALs @blally_md

#Leadership in #RadOnc. A mind-changing webinar with Dr. @marykge, Past President of @uicc @UHN and @ElianeGarlock @VCU . Soon to be available as part of our Master Your Residency Survival Series under @ARRO_org resources with the support of @ASTRO_org. @MaimoHealth @ACROresident @caro_acro_ca

Join us for a GU Malignancy Webinar with @TylerSbrt on Jan 20th! Register here: us02web.zoom.us/meeting/regist…

🎉 Happy New Year from your friends at @ACRORadOnc, @ACROresident, & @ACROSEALs! We look forward to connecting with many of you next month at #ACRO2026!

The correct answer is D. Indomethacin pubmed.ncbi.nlm.nih.gov/11741055/

The correct answer is D. Indomethacin pubmed.ncbi.nlm.nih.gov/11741055/

Test Your Knowledge Tuesdays! What drug can be used in place of RT for Heterotopic Ossification as prophylaxis? A. Dexamethasone B. Octreotide C. Denosumab D. Indomethacin